Influence of Genetic Variation in PDE3A on Endothelial Function and Stroke.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE
    • Publication Information:
      Publication: : Hagerstown, MD : Lippincott, Williams & Wilkins
      Original Publication: [Dallas, Tex.] : [American Heart Association], [©1979]-
    • Subject Terms:
    • Abstract:
      We aimed to characterize the genetics of endothelial function and how this influences risk for cardiovascular diseases such as ischemic stroke. We integrated genetic data from a study of ultrasound flow-mediated dilatation of brachial artery in adolescents from ALSPAC (Avon Longitudinal Study of Parents and Children; n=5214) with a study of ischemic stroke (MEGASTROKE: n=60 341 cases and 452 969 controls) to identify variants that confer risk of ischemic stroke through altered endothelial function. We identified a variant in PDE3A (Phosphodiesterase 3A), encoding phosphodiesterase 3A, which was associated with flow-mediated dilatation in adolescents (9-12 years of age; β[SE], 0.38 [0.070]; P =3.8×10 -8 ) and confers risk of ischemic stroke (odds ratio, 1.04 [95% CI, 1.02-1.06]; P =5.2×10 -6 ). Bayesian colocalization analyses showed the same underlying variation is likely to lead to both associations (posterior probability, 97%). The same variant was associated with flow-mediated dilatation in a second study in young adults (age, 24-27 years; β[SE], 0.47 [0.23]; P =0.047) but not in older adults (β[SE], -0.012 [0.13]; P =0.89). We conclude that a genetic variant in PDE3A influences endothelial function in early life and leads to increased risk of ischemic stroke. Subtle, measurable changes to the vasculature that are influenced by genetics also influence risk of ischemic stroke.
    • References:
      Hypertension. 2010 May;55(5):1075-85. (PMID: 20351340)
      Nature. 2010 Oct 28;467(7319):1061-73. (PMID: 20981092)
      J Am Heart Assoc. 2014 Aug 18;3(4):. (PMID: 25134680)
      Exp Physiol. 2008 Jan;93(1):121-7. (PMID: 17933861)
      Int J Epidemiol. 2013 Feb;42(1):111-27. (PMID: 22507743)
      Nat Genet. 2018 Sep;50(9):1225-1233. (PMID: 29892015)
      Ann Neurol. 2014 Sep;76(3):379-92. (PMID: 25043464)
      Exp Gerontol. 1999 Jul;34(4):549-57. (PMID: 10817810)
      Nature. 2015 Oct 1;526(7571):68-74. (PMID: 26432245)
      Circulation. 2009 Feb 24;119(7):1005-12. (PMID: 19204308)
      Nat Genet. 2017 Mar;49(3):416-425. (PMID: 28166213)
      Nat Genet. 2006 Aug;38(8):904-9. (PMID: 16862161)
      Hum Genet. 2015 Apr;134(4):393-403. (PMID: 25576479)
      Nat Genet. 2019 Feb;51(2):237-244. (PMID: 30643251)
      Cardiovasc Res. 2005 May 1;66(2):286-94. (PMID: 15820197)
      Int J Stroke. 2018 Jul;13(5):530-538. (PMID: 28906205)
      Eur Heart J. 2010 Jun;31(12):1502-10. (PMID: 20421227)
      Circulation. 2004 Nov 2;110(18):2918-23. (PMID: 15505080)
      Stroke. 2005 Apr;36(4):782-6. (PMID: 15746463)
      Gigascience. 2015 Feb 25;4:7. (PMID: 25722852)
      Nat Commun. 2018 Dec 3;9(1):5141. (PMID: 30510157)
      Nat Genet. 2016 Jul;48(7):709-17. (PMID: 27182965)
      Nat Genet. 2017 Jul;49(7):1113-1119. (PMID: 28530674)
      Int J Epidemiol. 2013 Feb;42(1):97-110. (PMID: 22507742)
      Nat Genet. 2013 Jun;45(6):580-5. (PMID: 23715323)
      Lancet Neurol. 2018 Jun;17(6):509-518. (PMID: 29778364)
      Circulation. 2007 Mar 13;115(10):1285-95. (PMID: 17353456)
      Circ Res. 2018 Feb 2;122(3):433-443. (PMID: 29212778)
      Nat Genet. 2018 Nov;50(11):1505-1513. (PMID: 30297969)
      Neuron. 2013 Nov 20;80(4):844-66. (PMID: 24267647)
      Circulation. 2012 Aug 7;126(6):753-67. (PMID: 22869857)
      PLoS Genet. 2014 Jun 19;10(6):e1004423. (PMID: 24945404)
      Bioinformatics. 2015 Nov 1;31(21):3555-7. (PMID: 26139635)
      Int J Epidemiol. 2008 Dec;37(6):1220-6. (PMID: 18263651)
      Lancet Neurol. 2010 Oct;9(10):959-68. (PMID: 20833591)
    • Grant Information:
      MC_EX_MR/M009203/1 United Kingdom MRC_ Medical Research Council; MC_PC_15018 United Kingdom MRC_ Medical Research Council; G9521010 United Kingdom MRC_ Medical Research Council; MR/M009203/1 United Kingdom MRC_ Medical Research Council; R01 NS103924 United States NS NINDS NIH HHS; G9815508 United Kingdom MRC_ Medical Research Council; RG/16/4/32218 United Kingdom BHF_ British Heart Foundation; K23 NS086873 United States NS NINDS NIH HHS; MC_PC_14089 United Kingdom MRC_ Medical Research Council; 102215/2/13/2 United Kingdom MRC_ Medical Research Council; MC_PC_19009 United Kingdom MRC_ Medical Research Council
    • Contributed Indexing:
      Keywords: cyclic nucleotide phosphodiesterases, type 3; genetics; genome-wide association study; stroke; vascular endothelium
    • Accession Number:
      EC 3.1.4.17 (Cyclic Nucleotide Phosphodiesterases, Type 3)
      EC 3.1.4.17 (PDE3A protein, human)
    • Publication Date:
      Date Created: 20191224 Date Completed: 20201021 Latest Revision: 20240726
    • Publication Date:
      20240726
    • Accession Number:
      PMC7055937
    • Accession Number:
      10.1161/HYPERTENSIONAHA.119.13513
    • Accession Number:
      31865795